231 related articles for article (PubMed ID: 9669991)
41. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.
Finan RR; Tamim H; Ameen G; Sharida HE; Rashid M; Almawi WY
Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960
[TBL] [Abstract][Full Text] [Related]
42. A prothrombin gene mutation is significantly associated with venous thrombosis.
Kapur RK; Mills LA; Spitzer SG; Hultin MB
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2875-9. PubMed ID: 9409269
[TBL] [Abstract][Full Text] [Related]
43. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
Nishank SS; Singh MP; Yadav R
Eur J Haematol; 2013 Nov; 91(5):462-6. PubMed ID: 23992124
[TBL] [Abstract][Full Text] [Related]
44. Prevalence and association of the factor V Leiden and prothrombin G20210A in healthy subjects and patients with venous thromboembolism.
Coen D; Zadro R; Honović L; Banfić L; Stavljenić Rukavina A
Croat Med J; 2001 Aug; 42(4):488-92. PubMed ID: 11471205
[TBL] [Abstract][Full Text] [Related]
45. G20210A mutation in prothrombin gene and risk of myocardial infarction, stroke, and venous thrombosis in a large cohort of US men.
Ridker PM; Hennekens CH; Miletich JP
Circulation; 1999 Mar; 99(8):999-1004. PubMed ID: 10051291
[TBL] [Abstract][Full Text] [Related]
46. The association of prothrombin A19911G polymorphism with plasma prothrombin activity and venous thrombosis: results of the MEGA study, a large population-based case-control study.
Chinthammitr Y; Vos HL; Rosendaal FR; Doggen CJ
J Thromb Haemost; 2006 Dec; 4(12):2587-92. PubMed ID: 17059428
[TBL] [Abstract][Full Text] [Related]
47. High prevalence of factor V Leiden and prothrombin G20101A mutations in Kashmiri patients with venous thromboembolism.
Shafia S; Zargar MH; Khan N; Ahmad R; Shah ZA; Asimi R
Gene; 2018 May; 654():1-9. PubMed ID: 29454086
[TBL] [Abstract][Full Text] [Related]
48. Effect of prothrombin 19911 A>G polymorphism on the risk of cerebral sinus-venous thrombosis.
Martinelli I; Bucciarelli P; De Stefano V; Passamonti SM; Menegatti M; Tormene D; Tosetto A; Mannucci PM
Eur J Neurol; 2010 Dec; 17(12):1482-5. PubMed ID: 20482605
[TBL] [Abstract][Full Text] [Related]
49. The Contributions of Thrombophilic Mutations to Genetic Susceptibility to Deep Venous Thrombosis in Iraqi Patients.
Al-Allawi NA; Badi AI; Goran MA; Nerweyi FF; Ballo HM; Al-Mzury NT
Genet Test Mol Biomarkers; 2015 Sep; 19(9):500-4. PubMed ID: 26196588
[TBL] [Abstract][Full Text] [Related]
50. Increased risk of venous thrombosis in oral-contraceptive users who are carriers of factor V Leiden mutation.
Vandenbroucke JP; Koster T; Briët E; Reitsma PH; Bertina RM; Rosendaal FR
Lancet; 1994 Nov; 344(8935):1453-7. PubMed ID: 7968118
[TBL] [Abstract][Full Text] [Related]
51. Prevalence of prothrombin G20210A, factor V G1691A (Leiden), and methylenetetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR.
Hessner MJ; Luhm RA; Pearson SL; Endean DJ; Friedman KD; Montgomery RR
Thromb Haemost; 1999 May; 81(5):733-8. PubMed ID: 10365746
[TBL] [Abstract][Full Text] [Related]
52. Prothrombin 20210 G: a mutation and Factor V Leiden mutation in women with a history of severe preeclampsia and (H)ELLP syndrome.
van Pampus MG; Wolf H; Koopman MM; van den Ende A; Buller HR; Reitsma PH
Hypertens Pregnancy; 2001; 20(3):291-8. PubMed ID: 12044337
[TBL] [Abstract][Full Text] [Related]
53. Thrombin generation and D-dimer concentrations in a patient cohort investigated for venous thromboembolism. Relations to venous thrombosis, factor V Leiden and prothrombin G20210A. The LIST study.
Chaireti R; Jennersjö C; Lindahl TL
Thromb Res; 2009 Jun; 124(2):178-84. PubMed ID: 19232683
[TBL] [Abstract][Full Text] [Related]
54. Combined genetic defect (homogeneity for factor V Leiden and heterogeneity for prothrombin G20210A allele), in a young patient, with recurrent deep vein thrombosis and serious postphlebitic syndrome--a case report.
Mitsis M; Ioannou H; Eleftheriou A; Nousias V; Basioukas C; Kakosimos G; Batsis C; Vartholomatos G
Angiology; 2000 Apr; 51(4):325-9. PubMed ID: 10779003
[TBL] [Abstract][Full Text] [Related]
55. Detection of factor V leiden and prothrombin gene mutations in patients who died with thrombotic events.
Ranguelov RD; Rosenthal N; Bromley C; Vasef MA
Arch Pathol Lab Med; 2002 Oct; 126(10):1193-6. PubMed ID: 12296757
[TBL] [Abstract][Full Text] [Related]
56. Inherited thrombophilia is associated with deep vein thrombosis in a Colombian population.
Torres JD; Cardona H; Alvarez L; Cardona-Maya W; Castañeda SA; Quintero-Rivera F; Cadavid A; Bedoya G; Tobón L
Am J Hematol; 2006 Dec; 81(12):933-7. PubMed ID: 16917913
[TBL] [Abstract][Full Text] [Related]
57. [From gene to disease; risk factors for venous thrombosis: factor V Leiden and prothrombin 20210A].
Reitsma PH; van de Stolpe A
Ned Tijdschr Geneeskd; 2001 Sep; 145(38):1843-5. PubMed ID: 11593787
[TBL] [Abstract][Full Text] [Related]
58. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease.
Liebman HA; Kashani N; Sutherland D; McGehee W; Kam AL
Gastroenterology; 1998 Oct; 115(4):830-4. PubMed ID: 9753484
[TBL] [Abstract][Full Text] [Related]
59. Familial thrombophilia and the occurrence of fetal growth restriction.
Martinelli P; Grandone E; Colaizzo D; Paladini D; Sciannamé N; Margaglione M; Di Minno G
Haematologica; 2001 Apr; 86(4):428-31. PubMed ID: 11325651
[TBL] [Abstract][Full Text] [Related]
60. [Multigenic thrombophilia: genetic anomaly of factor II and mutation of factor V Leiden. Study in a French family].
Conard J; Mabileau-Brouzes C; Horellou MH; Elalamy I; Samama MM
Presse Med; 1997 Jun; 26(20):951-3. PubMed ID: 9238178
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
